Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
89.9 CHF | +0.87% | +6.47% | +6.03% |
Apr. 24 | BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating | MT |
Apr. 24 | Novartis Says New Malaria Drug Formulation Safe and Effective for Babies | MT |
Filters
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG